Has Alan Koletsky received payments from drug or device companies?

Yes. Drug and device makers reported $857,592 in general payments to Alan Koletsky across 518 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alan Koletsky did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alan Koletsky come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alan Koletsky

Medical Oncology · Delray Beach, FLNPI 1952359234

Payments from drug & device makers

$857,592in general payments, 2019–2025

Across 518 payments — averaging $1655.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$261K
Genentech, Inc.$149K
Seagen Inc.$116K
Eisai Inc.$108K
Exelixis Inc.$96K
Bayer$81K
plus $46K from 37 others

What the payments were for

Consulting fees$7,11838%
Speaking & faculty fees$3,89021%
Travel & lodging$1,6169%
Food & beverage$5,58730%
Education$7174%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	77	$260,979
Genentech, Inc.	27	$149,446
Seagen Inc.	20	$116,453
Eisai Inc.	50	$108,075
Exelixis Inc.	51	$96,041
Bayer	50	$81,066
Clovis Oncology, Inc.	15	$25,017
AstraZeneca	15	$9,209
Pfizer	47	$3,440
Astellas Pharma Global Development	1	$2,241
AVEO Pharmaceuticals, Inc.	4	$1,137
Johnson & Johnson	29	$864
Sirtex Medical Inc	5	$593
Novartis	21	$514
Astellas Pharma US Inc	12	$294
Genentech USA, Inc.	8	$292
E.r. Squibb & Sons, L.L.C.	17	$254
Boehringer Ingelheim	2	$219
Sanofi	8	$162
Jazz Pharmaceuticals Inc.	4	$153
Lilly USA, LLC	8	$150
Bristol Myers Squibb	6	$120
Puma Biotechnology, Inc.	1	$114
Amgen	6	$101
Deciphera Pharmaceuticals Inc.	4	$73
AbbVie	3	$56
Pharmacyclics LLC, An Abbvie Company	2	$55
Blue Earth Diagnostics	2	$50
Mirati Therapeutics, Inc.	2	$46
Takeda Pharmaceuticals U.S.A., Inc.	3	$45
Taiho Oncology, Inc.	2	$41
EMD Serono, Inc.	2	$40
Sobi, Inc	2	$39
Incyte Corporation	2	$36
Dova Pharmaceuticals	2	$28
Foundation Medicine, Inc.	1	$26
Tersera Therapeutics LLC	1	$21
Beigene USA, Inc.	1	$21
Ipsen Biopharmaceuticals, Inc	1	$21
Array Biopharma Inc	1	$20
Karyopharm Therapeutics Inc.	1	$18
Aurobindo Pharma USA, Inc.	1	$14
AMAG Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$857,592 in reported general payments places this provider in the 80th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Other medical oncology in Delray Beach

Zeynep ErogluTampa$30.9M
Manish PatelSarasota$29.7M
Jad ChahoudTampa$21.8M
Maen HusseinTavares$18.4M
Patrick HwuTampa$18M
Gail WrightHudson$13.8M
Adil DaudTampa$13.3M
Lowell HartFort Myers$10.1M
Judy WangSarasota$9.8M
Jonathan StrosbergTampa$9.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →